Hasil Pencarian - Anas Hamad
- Menampilkan 1 - 20 hasil dari 20
-
1
Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation oleh Shereen Elazzazy, Nour Hisham Al-Ziftawi, Mohamed Izham Mohamed Ibrahim, Salha Bujassoum, Anas Hamad, Anas Hamad
Diterbitkan 2024-07-01Dapatkan teks lengkap
Artikel -
2
The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study oleh Nour Hisham Al-Ziftawi, Shereen Elazzazy, Mohammed Fasihul Alam, Asrul Shafie, Anas Hamad, Anas Hamad, Salha Bbujassoum, Mohamed Izham Mohamed Ibrahim
Diterbitkan 2023-12-01Dapatkan teks lengkap
Artikel -
3
HER2-low non-metastatic breast cancer in Qatar—a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis oleh Ahmed Kardousha, Wafaa Shehada, Ahmed Basha, Sahar Nasser, Mufid El Mistiri, Anas Hamad, Anas Hamad, Salha Bujassoum Al-Bader, Shereen Elazzazy, Shereen Elazzazy
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
4
-
5
-
6
Do psychological and sociological capitals predict employee engagement oleh AlKahtani, Nasser Saad, Sulphey, M.M., Delany, Kevin, Adow, Anas Hamad Elneel
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
7
-
8
Cost-effectiveness of -glutamine versus crizanlizumab for adults with sickle cell disease: model focused on reducing pain episode costs from Qatar’s healthcare perspective oleh Ahmad M Adel, Dina Abushanab, Daoud Al-Badriyeh, Anas Hamad, Awni Alshurafa, Mohamed A Yassin
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
9
-
10
Survival and metastasis in muscle-invasive bladder cancer patients who present with indeterminate pulmonary nodules before treatment oleh Ali Al-daghmin, Sohaib Alhamss, Hani Al-Najjar, Ibrahim Al-Saidi, Khloud Al-Qasem, Ibrahim Abukhiran, Anas Hamad, Muna Alhusban
Diterbitkan 2019-01-01Dapatkan teks lengkap
Artikel -
11
Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis oleh Ahmad Adel MSc, Dina Abushanab MSc (Pharm), Anas Hamad PhD, Mohammad Abdulla MD, Mohamed Izham PhD, Mohamed Yassin MD
Diterbitkan 2021-04-01Dapatkan teks lengkap
Artikel -
12
Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor oleh Regina Padmanabhan, Hadeel Kheraldine, Hadeel Kheraldine, Ishita Gupta, Ishita Gupta, Nader Meskin, Anas Hamad, Semir Vranic, Ala-Eddin Al Moustafa, Ala-Eddin Al Moustafa
Diterbitkan 2022-12-01Dapatkan teks lengkap
Artikel -
13
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries oleh Anas Hamad, Shereen Elazzazy, Ruba Y. Taha, Hani Osman, Sana Alblooshi, Islam Elkonaissi, Mustaqeem A. Siddiqui, Khalil Al-Farsi, Mohammed Al Lamki, Sali Emara, Gihan H. Elsisi
Diterbitkan 2024-07-01Dapatkan teks lengkap
Artikel -
14
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review oleh Nabil E. Omar, Kareem A. El-Fass, Abdelrahman I. Abushouk, Noha Elbaghdady, Abd Elmonem M. Barakat, Ahmed E. Noreldin, Dina Johar, Mohamed Yassin, Anas Hamad, Shereen Elazzazy, Said Dermime
Diterbitkan 2020-10-01Dapatkan teks lengkap
Artikel -
15
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nation... oleh Rawan Dawoud, Harman Saman, Kakil Rasul, Farah Jibril, Arwa Sahal, Randa Al-Okka, Yaser Mahfouz, Nabil E. Omar, Anas Hamad, Reyad Mohsen, Aladdin Kanbour, Naim Battikh, Prem Chandra, Shereen Elazzazy
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
16
Post‐COVID‐19‐associated multiorgan complications or “long COVID” with literature review and management strategy discussion: A meta‐analysis oleh Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Syed Ata ul Munamm, Rohit Sharma, Kahtan Fadah, Shereen Elazzazy, Anas Hamad, Osama Said Abu Tabar, Nabil E. Omar
Diterbitkan 2023-04-01Dapatkan teks lengkap
Artikel -
17
Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP) oleh Anas Hamad, Shereen Elazzazy, Salha Bujassoum, Kakil Rasul, Javid Gaziev, Honar Cherif, Zakiya Al-Boloshi, Yolande Hanssens, Ayman Saleh, Hadi Abu Rasheed, Daoud Al-Badriyeh, Ahmed Babiker, Amid Abu Hmaidan, Moza Al-Hail
Diterbitkan 2023-01-01Dapatkan teks lengkap
Artikel -
18
Pharmacy faculty experiences with student academic entitlement: a multinational study from the Arab world oleh Dalal Hammoudi Halat, Mervat M. Alsous, Ali Azeez Al-Jumaili, Ahmed Malki, Kawther Khalid Ahmed, Anas Hamad, Rula Darwish, Dixon Thomas, Salma Bukhatwa, Maher Khdour, Nora Alkhudair, Abdullah Ali Al Balushi, Sherif Khalifa, Naser Z. Alsharif, Mohamad Rahal
Diterbitkan 2024-04-01Dapatkan teks lengkap
Artikel -
19
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia oleh Ahmad Basha, Mohamed Izham Mohamed Ibrahim, Anas Hamad, Prem Chandra, Nabil E. Omar, Mohamed Abdul Jaber Abdullah, Mahmood B. Aldapt, Radwa M. Hussein, Ahmed Mahfouz, Ahmad A. Adel, Hawraa M. Shwaylia, Yaslem Ekeibed, Rami AbuMousa, Mohamed A. Yassin
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel -
20
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia. oleh Ahmad Basha, Mohamed Izham Mohamed Ibrahim, Anas Hamad, Prem Chandra, Nabil E Omar, Mohamed Abdul Jaber Abdullah, Mahmood B Aldapt, Radwa M Hussein, Ahmed Mahfouz, Ahmad A Adel, Hawraa M Shwaylia, Yaslem Ekeibed, Rami AbuMousa, Mohamed A Yassin
Diterbitkan 2021-01-01Dapatkan teks lengkap
Artikel